Hyogo, Japan

Yoshie Sugiyama


Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 24(Granted Patents)


Location History:

  • Takarazuka, JP (1987 - 1988)
  • Hyogo, JP (1989 - 1990)

Company Filing History:


Years Active: 1987-1990

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Profile of Inventor Yoshie Sugiyama**

Introduction

Yoshie Sugiyama is a prominent inventor based in Hyogo, Japan. She is known for her innovative contributions in the pharmaceutical field, particularly in the treatment of cerebrovascular diseases and hypertension. With a portfolio of four patents, her work is at the forefront of medical advancements.

Latest Patents

Yoshie's latest patents include significant developments in diphenylpyridazine compounds and diphenylpyridine compounds. The diphenylpyridazine compounds are useful in treating cerebrovascular disease and involve a specific formula where R^1 can be a variety of piperazinyl substitutions. In another patent, she has developed compounds targeting hypertension and cardiovascular diseases, again utilizing a formula that includes various piperazinyl groups.

Career Highlights

Sugiyama has built her career at Fujisawa Pharmaceutical Company, Ltd., where she has dedicated herself to research and innovation. Her role at the company has allowed her to focus on creating effective pharmaceutical solutions aimed at improving patient health outcomes.

Collaborations

Throughout her career, Yoshie has collaborated with several notable colleagues, including Takao Takaya and Hisashi Takasugi. These partnerships have enriched her work and contributed to her success as an inventor in the pharmaceutical sector.

Conclusion

Yoshie Sugiyama exemplifies the spirit of innovation in the medical field with her cutting-edge research and patent contributions. Her work continues to make a substantial impact on the treatment of serious health conditions, highlighting the importance of inventors in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…